Back to Archived Journals » Core Evidence » Volume 4 » default

Core Evidence ceased publishing in February 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Archive: Volume 4, 2009

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Peter Deibert, Carola Xander, Hubert E Blum, et al

Core Evidence 2009, 4:247-258

Published Date: 11 December 2009

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al

Core Evidence 2009, 4:215-245

Published Date: 17 November 2009

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Core Evidence 2009, 4:207-213

Published Date: 5 October 2009

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Katherine A Thornton

Core Evidence 2009, 4:191-198

Published Date: 21 August 2009

Agomelatine: The evidence for its place in the treatment of depression

Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller

Core Evidence 2009, 4:171-179

Published Date: 5 August 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Hans-Jürgen Stellbrink

Core Evidence 2009, 4:149-158

Published Date: 22 July 2009

Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Kavya Ramkumar, Nouri Neamati

Core Evidence 2009, 4:131-147

Published Date: 2 July 2009

Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti

Core Evidence 2009, 4:113-129

Published Date: 1 July 2009

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Ayman I Omar, Warren P Mason

Core Evidence 2009, 4:93-111

Published Date: 26 June 2009

Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Melissa Li-Ng, Joseph G Verbalis

Core Evidence 2009, 4:83-92

Published Date: 25 June 2009

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Daniel Z Lieberman, Suena H Massey

Core Evidence 2009, 4:67-82

Published Date: 25 June 2009

Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell

Core Evidence 2009, 4:49-65

Published Date: 18 June 2009

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Hari A Deshpande, Scott Gettinger, Julie Ann Sosa

Core Evidence 2009, 4:43-48

Published Date: 10 June 2009

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Kai M Beeh, Jutta Beier

Core Evidence 2009, 4:37-41

Published Date: 18 June 2009

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Angelo L Gaffo, Kenneth G Saag

Core Evidence 2009, 4:25-36

Published Date: 23 June 2009

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Jean-Marie Krzesinski, Eric P Cohen

Core Evidence 2009, 4:1-11

Published Date: 17 June 2009